A cost comparison of infertility treatment for clomiphene resistant polycystic ovary syndrome

References

• Arey LB. The degree of normal menstrual irregularity. Am J Obstet Gynecol 1939; 37: 12–29.
   Google Scholar
• Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968; 203: 377–80.
   Google Scholar
• Wood C, Larsen L, Williams R. Menstrual characteristics of 2343 women attending the Shepherd Foundation. Aust NZ J Obstet Gynaecol 1979; 19: 107–10.
   Google Scholar
• Bachmann GA, Kemmann E. Prevalence of oligomenorrhoea and amenorrhoea in a college population. Am J Obstet Gynecol 1982; 144: 98–102.
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989; 31: 87–120.
   PubMed Web of Science ®Google Scholar
• Polson D, Kiddy D, Mason H, Franks S. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and non responders. Fertil Steril 1989; 51: 30–4.
   PubMed Web of Science ®Google Scholar
• MacGregor AH, Johnson JE, Bunde CA. Further clinical experience with clomiphene citrate. Fertil Steril 1968; 19: 616–22.
   PubMed Web of Science ®Google Scholar
• Hull MGR. Gonadotrophin therapy in anovulatory infertility. In: Howles CM, ed. Gonadotrophin, gonadotrophinreleasing hormone analogues and growth factors in infertility: future perspectives. Oxford: Alden Press, 1991: 56–70.
   Google Scholar
• Hull MGR. Infertility treatment: relative effectiveness of conventional and assisted conception methods. Hum Reprod 1992; 7: 785–96.
   PubMed Web of Science ®Google Scholar
• Franks S, Polson D, Sagle M, Hamilton-Fairley D, White D. Low-dose gonadotrophin regimens for induction of ovulation. In: Filicori M, Flamigni C eds. Ovulation induction, basic science and clinical advances. Amsterdam: Exerpta Medica, 1994: 145–52.
   Google Scholar
• Lessing J, Amit A, Libal Y, Yovel I, Kogosowski A, Peyser M. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer. Fertil Steril 1991; 56: 75–8.
   Google Scholar
• Bergh C, Bryman I, Nilsson L, Janson PO. Results of gonadotrophin stimulation with the option to convert cycles to in vitro fertilization in cases of multifollicular development. Acta Obstet Gynecol Scand 1998; 77: 68–73.
   Google Scholar
• Dale PO, Tanbo T, Åbyholm T. In-vitro fertilization in infertile women with the polycystic ovary syndrome. Hum Reprod 1991; 6: 238–41.
   Google Scholar
• Homburg R, Berkowitz D, Levy T, Feldberg D, Ashkenazi J, Ben-Rafael Z. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993; 60: 858–63.
   Google Scholar
• Conway G, Honour J, Jacobs H. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989; 30: 459–70.
   Google Scholar
• Fridström M, Sjöblom P, Pousette Å, Hillensjö T. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urifollitropin. Eur J Endocrinol 1997; 136: 488–92.
   PubMedGoogle Scholar
• Ryan M, Donaldson C. Assessing the costs of assisted reproductive techniques. Br J Obstet Gynaecol 1996; 103: 198–201.
   Google Scholar
• Watson AJS, Gupta JK, O’Donovan P, Dalton ME, Lilford RJ. The results of tubal surgery in the treatment of infertility in two non-specialist hospitals. Br J Obstet Gynaecol 1990; 96: 561–8.
   Google Scholar
• Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilization. N Engl J Med 1994; 331: 239–43.
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–61.
   PubMed Web of Science ®Google Scholar
• Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10: 2705–12.
   PubMed Web of Science ®Google Scholar
• Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol 1992; 99: 128–31.
   Google Scholar
• Hultling C, Rosenlund B, Levi R, Fridström M, Sjöblom P, Hillensjö T Assisted ejaculation and in-vitro fertilization in the treatment of infertile spinal cord-injured men: the role of intracytoplasmatic sperm injection. Hum Reprod 1997; 12: 499–502.
   PubMed Web of Science ®Google Scholar
• Homburg R, Levy T, Berkowitz D, Farchi J, Feldberg D, Ashkenazi J et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovary syndrome. Fertil Steril 1993; 59: 527–31.
   PubMedGoogle Scholar
• Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993; 8: 959–64.
   PubMed Web of Science ®Google Scholar
• van der Meer M, Hompes PGA, Scheele F, Schoute E, Popp-Snijders C, Schoemaker J. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study. Fertil Steril 1996; 66: 571–6.
   Google Scholar
• Dale PO, Tanbo T, Lunde O, Åbyholm T Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome. Acta Obstet Gynecol Scand 1993; 72: 43–6.
   PubMed Web of Science ®Google Scholar
• Homburg R, Levy T, Ben-Rafael Z. A comparative prospective study of conventional regimen with chronic low- dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 1995; 63: 729–33.
   Google Scholar